In Vivo Antitumor Activity of Tumor-Infiltrating Lymphocytes Expanded in Recombinant Interleukin-2
- 1 November 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 79 (5) , 1067-1075
- https://doi.org/10.1093/jnci/79.5.1067
Abstract
A method was described for the generation of cells from tumor-bearing mice; these cells were capable of exhibiting significant antitumor reactivity when adoptively transferred into tumor-bearing hosts. Tumor cell suspensions from a variety of tumors were able to be separated using enzymatic techniques and they were cultured in medium containing recombinant interleukin-2. Activated infiltrating lymphocytes within these tumors expanded; and, by 6–8 days after initiation of culture, lymphocytes predominated and were able to grow to large numbers. The adoptive transfer of these tumor-infiltrating lymphocytes (TILs) made possible mediation of the reduction of established 3-day pulmonary micrometastases from 5 of 7 tumors tested, including two 3-methylcholanthrene (CAS: 56-49-5)-induced sarcomas, one 1,2-dimethylhydrazine (CAS: 540-73-8)-induced colon carcinoma, and the B16 melanoma, all in C57BL/6 mice, as well as the 1660 bladder carcinoma in BALB/c mice. Approximately 2–4–106 transferred cells were capable of totally eliminating 3-day established metastases. These cells were thus 50 to 100 times more effective than lymphokine-activated killer cells in reducing established metastases; however, they could not be generated from all tumors. The concomitant administration of recombinant interleukin-2 enhanced, by approximately fivefold, the in vivo activity of these cells. The specificity of action of TILs in vivo was different from that determined by classic amputation rechallenge experiments. The tumor-infiltrating lymphocytes that developed this antitumor reactivity appeared to be Thy-1+ and did not bear the asialo GM1 antigen. The potent antitumor effect of these TILs, when transferred in vivo to tumor-bearing hosts, raises the possibility of utilizing similar approaches for the isolation and therapeutic use of lymphocytes with antitumor reactivity from human tumors.Keywords
This publication has 24 references indexed in Scilit:
- In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.The Journal of Immunology, 1980
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- In Vivo Elimination by Specific Effector Cells of an Established Syngeneic Rat Moloney Virus-Induced SarcomaThe Journal of Immunology, 1979
- INSITU LYMPHOID-CELLS OF MOUSE MAMMARY-TUMORS .2. CHARACTERIZATION OF LYMPHOID-CELLS SEPARATED FROM MOUSE MAMMARY-TUMORS1978
- INSITU LYMPHOID-CELLS OF MOUSE MAMMARY-TUMORS .1. DEVELOPMENT AND EVALUATION OF A METHOD FOR SEPARATION OF LYMPHOID-CELLS FROM MOUSE MAMMARY-TUMORS1978
- Isolation of T-Lymphocytes From Disaggregated Tumors, With High Purity and Good Percentage Recovery: Brief Communication23JNCI Journal of the National Cancer Institute, 1977
- Regression of Established Intradermal Tumors and Lymph Node Metastases in Guinea Pigs After Systemic Transfer of Immune Lymphoid CellsJNCI Journal of the National Cancer Institute, 1977
- INFLAMMATORY CELLS IN SOLID MURINE NEOPLASMS .4. CYTOLYTIC T LYMPHOCYTES ISOLATED FROM REGRESSING OR PROGRESSING MOLONEY SARCOMAS1977
- An Assessment of Intratumor Phagocytic and Surface Marker-Bearing Cells in a Series of Autochthonous and Early Passaged Chemically Induced Murine Sarcomas2JNCI Journal of the National Cancer Institute, 1976
- Two Functionally Distinct Anti-Tumor Effector Cells Isolated from Primary Murine Sarcoma Virus-Induced TumorsThe Journal of Immunology, 1976